Exploring the function of genetic variants in the non-coding genomic regions: Approaches for identifying human regulatory variants affecting gene expression

Briefings in Bioinformatics

Volumn 16, Issue 3, 2014, Pages 393-412

  Li, Mulin Jun ^a   Yan, Bin ^b   Sham, Pak Chung ^a   Wang, Junwen ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

Chromatin state; Function validation; Functional prediction; Genetic mapping; Regulatory variant; Transcriptional gene regulation

Indexed keywords

ALGORITHM; CHROMOSOMAL MAPPING; GENE EXPRESSION REGULATION; GENETIC VARIATION; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN GENOME; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PROCEDURES; REGULATORY SEQUENCE; SEQUENCE ALIGNMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ALGORITHMS; BASE SEQUENCE; CHROMOSOME MAPPING; GENE EXPRESSION REGULATION; GENETIC VARIATION; GENOME, HUMAN; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; POLYMORPHISM, SINGLE NUCLEOTIDE; REGULATORY SEQUENCES, NUCLEIC ACID; SEQUENCE ALIGNMENT;

EID: 84921837396     PISSN: 14675463     EISSN: 14774054     Source Type: Journal    
DOI: 10.1093/bib/bbu018     Document Type: Article

References (228)

1. Abecasis GR, Auton A, Brooks LD, et al. An integrated map of genetic variation from 1, 092 human genomes. Nature 2012;491:56-65.
2. Yngvadottir B, Macarthur DG, Jin H, et al. The promise and reality of personal genomics. Genome Biol 2009;10:237.
3. Peters BA, Kermani BG, Sparks AB, et al. Accurate wholegenome sequencing and haplotyping from 10 to 20 human cells. Nature 2012;487:190-5.
4. Hamosh A, Scott AF, Amberger JS, et al. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res 2005;33:D514-17.
5. Hindorff LA, Sethupathy P, Junkins HA, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 2009;106:9362-7.
6. Li MJ, Wang P, Liu X, et al. GWASdb: a database for human genetic variants identified by genome-wide association studies. Nucleic Acids Res 2012;40:D1047-54.
7. Sauna ZE, Kimchi-Sarfaty C. Understanding the contribution of synonymous mutations to human disease. Nat Rev Genet 2011;12:683-91.
8. Makrythanasis P, Antonarakis SE. Pathogenic variants in non-protein-coding sequences. Clin Genet 2013;84:422-8.
9. Benovoy D, Kwan T, Majewski J. Effect of polymorphisms within probe-target sequences on olignonucleotide microarray experiments. Nucleic Acids Res 2008;36:4417-23.
10. Pickrell JK, Marioni JC, Pai AA, et al. Understanding mechanisms underlying human gene expression variation with RNA sequencing. Nature 2010;464:768-72.
11. Zhao K, Lu ZX, Park JW, et al. GLiMMPS: Robust statistical model for regulatory variation of alternative splicing using RNA-seq data. Genome Biol 2013;14:R74.
12. Wang GS, Cooper TA. Splicing in disease: disruption of the splicing code and the decoding machinery. Nat Rev Genet 2007;8:749-61.
13. Fraser HB, Xie X. Common polymorphic transcript variation in human disease. Genome Res 2009;19:567-75.
14. Wan Y, Qu K, Zhang QC, et al. Landscape and variation of RNA secondary structure across the human transcriptome. Nature 2014;505:706-9.
15. Sethupathy P, Collins FS. MicroRNA target site polymorphisms and human disease. Trends Genet 2008;24:489-97.
16. Carbonell J, Alloza E, Arce P, et al. A map of human microRNA variation uncovers unexpectedly high levels of variability. GenomeMed 2012;4:62.
17. Halvorsen M, Martin JS, Broadaway S, et al. Disease-associated mutations that alter the RNA structural ensemble. PLoS Genet 2010;6:e1001074.
18. Martin JS, Halvorsen M, Davis-Neulander L, et al. Structural effects of linkage disequilibrium on the transcriptome. RNA 2012;18:77-87.
19. Kumar V, Westra HJ, Karjalainen J, et al. Human diseaseassociated genetic variation impacts large intergenic noncoding RNA expression. PLoS Genet 2013;9:e1003201.
20. Bhartiya D, Jalali S, Ghosh S, et al. Distinct patterns of genetic variations in potential functional elements in long noncoding RNAs. HumMut 2013;35:192-201.
21. Cannarozzi G, Schraudolph NN, Faty M, et al. A role for codon order in translation dynamics. Cell 2010;141:355-67.
22. Fredrick K, Ibba M. How the sequence of a gene can tune its translation. Cell 2010;141:227-9.
23. Li Q, Makri A, Lu Y, et al. Genome-wide search for exonic variants affecting translational efficiency. NatCommun 2013;4:2260.
24. Nackley AG, Shabalina SA, Tchivileva IE, et al. Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 2006;314:1930-3.
25. Tsai CJ, Sauna ZE, Kimchi-Sarfaty C, et al. Synonymous mutations and ribosome stalling can lead to altered folding pathways and distinct minima. JMol Biol 2008;383:281-91.
26. Bernstein BE, Birney E, Dunham I, et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012;489:57-74.
27. Gerstein MB, Kundaje A, Hariharan M, et al. Architecture of the human regulatory network derived from ENCODE data. Nature 2012;489:91-100.
28. Ward LD, Kellis M. Interpreting noncoding genetic variation in complex traits and human disease. Nat Biotechnol 2012;30:1095-6.
29. Schaub MA, Boyle AP, Kundaje A, et al. Linking disease associations with regulatory information in the human genome. GenomeRes 2012;22:1748-59.
30. Hardison RC. Genome-wide epigenetic data facilitate understanding of disease susceptibility association studies. J Biol Chem 2012;287:30932-40.
31. Maurano MT, Humbert R, Rynes E, et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 2012;337:1190-5.
32. Vernot B, Stergachis AB, Maurano MT, et al. Personal and population genomics of human regulatory variation. Genome Res 2012;22:1689-97.
33. Trynka G, Sandor C, Han B, et al. Chromatin marks identify critical cell types for fine mapping complex trait variants. Nat Genet 2013;45:124-30.
34. Parker SC, Stitzel ML, Taylor DL, et al. Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants. Proc Natl Acad Sci USA 2013;110:17921-6.
35. Arbiza L, Gronau I, Aksoy BA, et al. Genome-wide inference of natural selection on human transcription factor binding sites. Nat Genet 2013;45:723-29.
36. Fraser HB. Gene expression drives local adaptation in humans. Genome Res 2013;23:1089-96.
37. Gunderson KL, Steemers FJ, Lee G, et al. A genome-wide scalable SNP genotyping assay using microarray technology. Nat Genet 2005;37:549-54.
38. Metzker ML. Sequencing technologies-the next generation. Nat Rev Genet 2010;11:31-46.
39. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. AmJHum Genet 2007;81:559-75.
40. Marchini J, Howie B, Myers S, et al. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 2007;39:906-13.
41. Boyle AP, Hong EL, Hariharan M, et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res 2012;22:1790-97.
42. Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. NucleicAcids Res 2012;40:D930-4.
43. Li MJ, Wang LY, Xia Z, et al. GWAS3D: Detecting human regulatory variants by integrative analysis of genome-wide associations, chromosome interactions and histone modifications. Nucleic Acids Res 2013;41:W150-8.
44. Hemminki K, Lorenzo Bermejo J, Forsti A. The balance between heritable and environmental aetiology of human disease. Nat Rev Genet 2006;7:958-65.
45. Wang WY, Barratt BJ, Clayton DG, et al. Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet 2005;6:109-18.
46. McCarthy MI, Abecasis GR, Cardon LR, et al. Genome-wide association studies for complex traits:consensus, uncertainty and challenges. Nat Rev Genet 2008;9:356-69.
47. Altshuler DM, Gibbs RA, Peltonen L, et al. Integrating common and rare genetic variation in diverse human populations. Nature 2010;467:52-8.
48. On beyond GWAS. Nat Genet 2010;42:551.
49. Freedman ML, Monteiro AN, Gayther SA, et al. Principles for the post-GWAS functional characterization of cancer risk loci. Nat Genet 2011;43:513-18.
50. Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 2009;5:e1000529.
51. Browning BL, Browning SR. A unified approach to genotype imputation and haplotype-phase inference for large data sets of trios and unrelated individuals. AmJHum Genet 2009;84:210-23.
52. Marchini J, Howie B. Genotype imputation for genome-wide association studies. Nat Rev Genet 2010;11:499-511.
53. Udler MS, Tyrer J, Easton DF. Evaluating the power to discriminate between highly correlated SNPs in genetic association studies. Genet Epidemiol 2010;34:463-8.
54. Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 2010;26:2190-1.
55. Evangelou E, Ioannidis JP. Meta-analysis methods for genome-wide association studies and beyond. Am J Hum Genet 2013;14:379-89.
56. Li MJ, Sham PC, Wang J. Genetic variant representation, annotation and prioritization in the post-GWAS era. Cell Res 2012;22:1505-8.
57. Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature 2009;461:747-53.
58. Gorlov IP, Gorlova OY, Sunyaev SR, et al. Shifting paradigm of association studies: value of rare single-nucleotide polymorphisms. AmJHum Genet 2008;82:100-12.
59. Hunt KA, Mistry V, Bockett NA, et al. Negligible impact of rare autoimmune-locus coding-region variants on missing heritability. Nature 2013;498:232-5.
60. Cirulli ET, Goldstein DB. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat Rev Genet 2010;11:415-25.
61. Bamshad MJ, Ng SB, Bigham AW, et al. Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev Genet 2011;12:745-55.
62. Do R, Kathiresan S, Abecasis GR. Exome sequencing and complex disease: practical aspects of rare variant association studies. HumMol Genet 2012;21:R1-9.
63. Tang H, Jin X, Li Y, et al. A large-scale screen for coding variants predisposing to psoriasis. Nat Genet 2013.
64. Li B, Leal SM. Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data. AmJHum Genet 2008;83:311-21.
65. Wu MC, Lee S, Cai T, et al. Rare-variant association testing for sequencing data with the sequence kernel association test. AmJHum Genet 2011;89:82-93.
66. Neale BM, Rivas MA, Voight BF, et al. Testing for an unusual distribution of rare variants. PLoS Genet 2011;7:e1001322.
67. Lee S, Emond MJ, Bamshad MJ, et al. Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies. AmJHum Genet 2012;91:224-37.
68. Lee S, Wu MC, Lin X. Optimal tests for rare variant effects in sequencing association studies. Biostatistics 2012;13:762-75.
69. Edwards SL, Beesley J, French JD, et al. Beyond GWASs:illuminating the dark road from association to function. Am JHum Genet 2013;93:779-97.
70. Hou L, Zhao H. A review of post-GWAS prioritization approaches. Front Genet 2013;4:280.
71. Zhang X, Bailey SD, Lupien M. Laying a solid foundation for Manhattan-'setting the functional basis for the post-GWAS era'. Trends Genet 2014;30:140-9.
72. Gilissen C, Hoischen A, Brunner HG, et al. Unlocking Mendelian disease using exome sequencing. Genome Biol 2011;12:228.
73. Asan , Xu Y, Jiang H, et al. Comprehensive comparison of three commercial human whole-exome capture platforms. Genome Biol 2011;12:R95.
74. Wang W, Wei Z, Lam TW, et al. Next generation sequencing has lower sequence coverage and poorer SNP-detection capability in the regulatory regions. SciRep 2011;1:55.
75. Bromberg Y. Building a genome analysis pipeline to predict disease risk and prevent disease. JMol Biol 2013;425:3993-4005.
76. Pavlopoulos GA, Oulas A, Iacucci E, et al. Unraveling genomic variation from next generation sequencing data. BioDataMining 2013;6:13.
77. Xu F, Wang W, Wang P, et al. A fast and accurate SNP detection algorithm for next-generation sequencing data. Nat Commun 2012;3:1258.
78. DePristo MA, Banks E, Poplin R, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 2011;43:491-8.
79. Li MX, Gui HS, Kwan JS, et al. A comprehensive framework for prioritizing variants in exome sequencing studies of Mendelian diseases. Nucleic Acids Res 2012;40:e53.
80. Gilissen C, Hoischen A, Brunner HG, et al. Disease gene identification strategies for exome sequencing. Eur J Hum Genet 2012;20:490-7.
81. Weatheritt RJ, Babu MM. Evolution. The hidden codes that shape protein evolution. Science 2013;342:1325-6.
82. Stergachis AB, Haugen E, Shafer A, et al. Exonic transcription factor binding directs codon choice and affects protein evolution. Science 2013;342:1367-72.
83. Swami M. Whole-genome sequencing identifies Mendelian mutations. Nat RevGenet 2010;11:313.
84. Cooper DN, Chen JM, Ball EV, et al. Genes, mutations, and human inherited disease at the dawn of the age of personalized genomics. HumMut 2010;31:631-55.
85. Weedon MN, Cebola I, Patch AM, et al. Recessive mutations in a distal PTF1A enhancer cause isolated pancreatic agenesis. Nat Genet 2013.
86. Herdewyn S, Zhao H, Moisse M, et al. Whole-genome sequencing reveals a coding non-pathogenic variant tagging a non-coding pathogenic hexanucleotide repeat expansion in C9orf72 as cause of amyotrophic lateral sclerosis. HumMol Genet 2012;21:2412-19.
87. McDaniell R, Lee BK, Song L, et al. Heritable individualspecific and allele-specific chromatin signatures in humans. Science 2010;328:235-9.
88. Mackay TF, Stone EA, Ayroles JF. The genetics of quantitative traits: challenges and prospects. NatRevGenet 2009;10:565-77.
89. Dubois PC, Trynka G, Franke L, et al. Multiple common variants for celiac disease influencing immune gene expression. Nat Genet 2010;42:295-302.
90. Westra HJ, Peters MJ, Esko T, et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat Genet 2013;45:1238-43.
91. Edwards MD, Stuber CW, Wendel JF. Molecular-markerfacilitated investigations of quantitative-trait loci in maize. I. Numbers, genomic distribution and types of gene action. Genetics 1987;116:113-25.
92. Lander ES, Botstein D. Mapping mendelian factors underlying quantitative traits using RFLP linkage maps. Genetics 1989;121:185-99.
93. Zeng ZB. Theoretical basis for separation of multiple linked gene effects in mapping quantitative trait loci. Proc Natl Acad SciUSA 1993;90:10972--6.
94. Jansen RC. Interval mapping of multiple quantitative trait loci. Genetics 1993;135:205-11.
95. Jiang C, Zeng ZB. Multiple trait analysis of genetic mapping for quantitative trait loci. Genetics 1995;140:1111-27.
96. Doerge RW. Mapping and analysis of quantitative trait loci in experimental populations. Nat RevGenet 2002;3:43-52.
97. Frazer KA, Ballinger DG, Cox DR, et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007;449:851-61.
98. Sun W, Hu Y. eQTL mapping using RNA-seq data. Stat Biosci 2013;5:198-219.
99. Lappalainen T, Sammeth M, Friedlander MR, et al. Transcriptome and genome sequencing uncovers functional variation in humans. Nature 2013;501:506-11.
100. The Genotype-Tissue Expression (GTEx) project. Nat Genet 2013;45:580-5.
101. Michaelson JJ, Loguercio S, Beyer A. Detection and interpretation of expression quantitative trait loci (eQTL). Methods 2009;48:265-76.
102. Brown CD, Mangravite LM, Engelhardt BE. Integrative modeling of eQTLs and cis-regulatory elements suggests mechanisms underlying cell type specificity of eQTLs. PLoS Genet 2013;9:e1003649.
103. Qin J, Li MLJ, Wang PW, et al. ChIP-Array: combinatory analysis of ChIP-seq/chip and microarray gene expression data to discover direct/indirect targets of a transcription factor. Nucleic Acids Res 2011;39:W430-6.
104. Qin J, Li MJ, Wang P, et al. ProteoMirExpress: inferring microRNA and protein-centered regulatory networks from high-throughput proteomic and mRNA expression data. Mol Cell Proteomics 2013;12:3379-87.
105. Nicolae DL, Gamazon E, Zhang W, et al. Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet 2010;6:e1000888.
106. He X, Fuller CK, Song Y, et al. Sherlock: detecting genedisease associations by matching patterns of expression QTL and GWAS. AmJHum Genet 2013;92:667-80.
107. Conde L, Bracci PM, Richardson R, et al. Integrating GWAS and expression data for functional characterization of disease-associated SNPs: an application to follicular lymphoma. AmJHum Genet 2013;92:126-30.
108. Degner JF, Pai AA, Pique-Regi R, et al. DNase I sensitivity QTLs are a major determinant of human expression variation. Nature 2012;482:390-4.
109. Margueron R, Reinberg D. Chromatin structure and the inheritance of epigenetic information. NatRevGenet 2010;11:285-96.
110. Stower H. Gene regulation: from genetic variation to phenotype via chromatin. Nat Rev Genet 2013;14:824.
111. Furey TS, Sethupathy P. Genetics driving epigenetics. Science 2013;342:705-6.
112. Kilpinen H, Waszak SM, Gschwind AR, et al. Coordinated effects of sequence variation on DNA binding, chromatin structure, and transcription. Science 2013;342:744-7.
113. McVicker G, van de Geijn B, Degner JF, et al. Identification of genetic variants that affect histone modifications in human cells. Science 2013;342:747-9.
114. Kasowski M, Kyriazopoulou-Panagiotopoulou S, Grubert F, et al. Extensive variation in chromatin states across humans. Science 2013;342:750-2.
115. Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 2012;13:484-92.
116. Schubeler D. Molecular biology. Epigenetic islands in a genetic ocean. Science 2012;338:756-57.
117. Gibbs JR, van der Brug MP, Hernandez DG, et al. Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS Genet 2010;6:e1000952.
118. Heyn H, Moran S, Hernando-Herraez I, et al. DNA methylation contributes to natural human variation. GenomeRes 2013;23:1363-72.
119. Muers M. Gene expression: Disentangling DNA methylation. Nat Rev Genet 2013;14:519.
120. Gutierrez-Arcelus M, Lappalainen T, Montgomery SB, et al. Passive and active DNA methylation and the interplay with genetic variation in gene regulation. eLife 2013;2:e00523.
121. Nilsen TW, Graveley BR. Expansion of the eukaryotic proteome by alternative splicing. Nature 2010;463:457-63.
122. Wang ET, Sandberg R, Luo S, et al. Alternative isoform regulation in human tissue transcriptomes. Nature 2008;456:470-6.
123. Katz Y, Wang ET, Airoldi EM, et al. Analysis and design of RNA sequencing experiments for identifying isoform regulation. NatMethods 2010;7:1009-15.
124. Montgomery SB, Sammeth M, Gutierrez-Arcelus M, et al. Transcriptome genetics using second generation sequencing in a Caucasian population. Nature 2010;464:773-7.
125. Wu L, Candille SI, Choi Y, et al. Variation and genetic control of protein abundance in humans. Nature 2013;499:79-82.
126. Costanzo M, Baryshnikova A, Bellay J, et al. The genetic landscape of a cell. Science 2010;327:425-31.
127. Park S, Lehner B. Epigenetic epistatic interactions constrain the evolution of gene expression. Mol Syst Biol 2013;9:645.
128. Moore JH. The ubiquitous nature of epistasis in determining susceptibility to common human diseases. HumHeredity 2003;56:73-82.
129. Moore JH, Williams SM. Epistasis and its implications for personal genetics. AmJHum Genet 2009;85:309-20.
130. Cordell HJ. Detecting gene-gene interactions that underlie human diseases. Nat RevGenet 2009;10:392-404.
131. Zuk O, Hechter E, Sunyaev SR, et al. The mystery of missing heritability: Genetic interactions create phantom heritability. ProcNatl Acad SciUSA 2012;109:1193-8.
132. Cantor RM, Lange K, Sinsheimer JS. Prioritizing GWAS results: A review of statistical methods and recommendations for their application. AmJHum Genet 2010;86:6-22.
133. Wang Y, Liu G, Feng M, et al. An empirical comparison of several recent epistatic interaction detection methods. Bioinformatics 2011;27:2936-43.
134. Shang J, Zhang J, Sun Y, et al. Performance analysis of novel methods for detecting epistasis. BMC Bioinformatics 2011;12:475.
135. Zhang X, Huang S, Zou F, et al. TEAM: efficient twolocus epistasis tests in human genome-wide association study. Bioinformatics 2010;26:i217-27.
136. Wan X, Yang C, Yang Q, et al. BOOST: A fast approach to detecting gene-gene interactions in genome-wide casecontrol studies. AmJHum Genet 2010;87:325-40.
137. Yang C, He Z, Wan X, et al. SNPHarvester: a filteringbased approach for detecting epistatic interactions in genome-wide association studies. Bioinformatics 2009;25:504-11.
138. Wu J, Devlin B, Ringquist S, et al. Screen and clean: a tool for identifying interactions in genome-wide association studies. Genet Epidemiol 2010;34:275-85.
139. Zhang Y, Liu JS. Bayesian inference of epistatic interactions in case-control studies. Nat Genet 2007;39:1167-3.
140. Wan X, Yang C, Yang Q, et al. Predictive rule inference for epistatic interaction detection in genome-wide association studies. Bioinformatics 2010;26:30-7.
141. Lin X, Lee S, Christiani DC. Test for interactions between a genetic marker set and environment in generalized linear models. Biostatistics 2013;14:667-81.
142. Thomas D. Gene-environment-wide association studies:emerging approaches. Nat Rev Genet 2010;11:259-72.
143. Huang Y, Wuchty S, Przytycka TM. eQTL epistasis- challenges and computational approaches. Front Genet 2013;4:51.
144. Zhang W, Zhu J, Schadt EE, et al. A Bayesian partition method for detecting pleiotropic and epistatic eQTL modules. PLoSComputat Biol 2010;6:e1000642.
145. Gonzalez-Perez A, Lopez-Bigas N. Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. AmJ Hum Genet 2011;88:440-9.
146. Li MX, Kwan JS, Bao SY, et al. Predicting mendelian disease-causing non-synonymous single nucleotide variants in exome sequencing studies. PLoS Genet 2013;9:e1003143.
147. Sifrim A, Popovic D, Tranchevent LC, et al. eXtasy: variant prioritization by genomic data fusion. NatMethods 2013;10:1083-4.
148. Whyte WA, Orlando DA, Hnisz D, et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 2013;153:307-19.
149. Hnisz D, Abraham BJ, Lee TI, et al. Super-enhancers in the control of cell identity and disease. Cell 2013;155:934-7.
150. Phornphutkul C, Anikster Y, Huizing M, et al. The promoter of a lysosomal membrane transporter gene, CTNS, binds Sp-1, shares sequences with the promoter of an adjacent gene, CARKL, and causes cystinosis if mutated in a critical region. AmJHum Genet 2001;69:712-21.
151. Niimi T, Munakata M, Keck-Waggoner CL, et al. A polymorphism in the human UGRP1 gene promoter that regulates transcription is associated with an increased risk of asthma. AmJHum Genet 2002;70:718-25.
152. Hu XZ, Lipsky RH, Zhu G, et al. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive- compulsive disorder. AmJHumGenet 2006;78:815-26.
153. Theuns J, Brouwers N, Engelborghs S, et al. Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease. Am J Hum Genet 2006;78:936-46.
154. Musunuru K, Strong A, Frank-Kamenetsky M, et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature 2010;466:714-19.
155. French JD, Ghoussaini M, Edwards SL, et al. Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. AmJ Hum Genet 2013;92:489-503.
156. Tuupanen S, Turunen M, Lehtonen R, et al. The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. Nat Genet 2009;41:885-90.
157. Xie X, Mikkelsen TS, Gnirke A, et al. Systematic discovery of regulatory motifs in conserved regions of the human genome, including thousands of CTCF insulator sites. Proc Natl Acad Sci USA 2007;104:7145-50.
158. Engel N, Raval AK, Thorvaldsen JL, et al. Three-dimensional conformation at the H19/Igf2 locus supports a model of enhancer tracking. Hum Mol Genet 2008;17:3021-9.
159. Tolstorukov MY, Volfovsky N, Stephens RM, et al. Impact of chromatin structure on sequence variability in the human genome. Nat StructMol Biol 2011;18:510-15.
160. Prendergast JG, Semple CA. Widespread signatures of recent selection linked to nucleosome positioning in the human lineage. GenomeRes 2011;21:1777-87.
161. Gaffney DJ, McVicker G, Pai AA, et al. Controls of nucleosome positioning in the human genome. PLoS Genet 2012;8:e1003036.
162. Cowper-Sal lari R, Zhang X, Wright JB, et al. Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression. Nat Genet 2012;44:1191-8.
163. Wasserman NF, Aneas I, Nobrega MA. An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer. Genome Res 2010;20:1191-7.
164. Davison LJ, Wallace C, Cooper JD, et al. Long-range DNA looping and gene expression analyses identify DEXI as an autoimmune disease candidate gene. HumMol Genet 2012;21:322-33.
165. Wright JB, Brown SJ, Cole MD. Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells. Mol Cell Biol 2010;30:1411-20.
166. Camps J, Grade M, Nguyen QT, et al. Chromosomal breakpoints in primary colon cancer cluster at sites of structural variants in the genome. Cancer Res 2008;68:1284-95.
167. Gonzalez E, Kulkarni H, Bolivar H, et al. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 2005;307:1434-40.
168. Zhou J, Lemos B, Dopman EB, et al. Copy-number variation: the balance between gene dosage and expression in Drosophila melanogaster. Genome Biol Evol 2011;3:1014-24.
169. Pasmant E, Sabbagh A, Vidaud M, et al. ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J 2011;25:444-8.
170. Zhang H, Zeitz MJ, Wang H, et al. Long noncoding RNA-mediated intrachromosomal interactions promote imprinting at the Kcnq1 locus. J.Cell Biol 2014;204:61-75.
171. Matys V, Fricke E, Geffers R, et al. TRANSFAC: transcriptional regulation, from patterns to profiles. NucleicAcidsRes 2003;31:374-8.
172. Sandelin A, Alkema W, Engstrom P, et al. JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res 2004;32:D91-4.
173. Newburger DE, Bulyk ML. UniPROBE: an online database of protein binding microarray data on protein-DNA interactions. Nucleic Acids Res 2009;37:W202-8.
174. Bailey TL, Boden M, Buske FA, et al. MEME SUITE:tools for motif discovery and searching. Nucleic Acids Res 2009;37:W202-8.
175. Zhang G, Chen X, Chan L, et al. An SNP selection strategy identified IL-22 associating with susceptibility to tuberculosis in Chinese. Sci Reports 2011;1:20.
176. Kasowski M, Grubert F, Heffelfinger C, et al. Variation in transcription factor binding among humans. Science 2010;328:232-5.
177. Williamson I, Hill RE, Bickmore WA. Enhancers: from developmental genetics to the genetics of common human disease. Dev Cell 2011;21:17-19.
178. Macintyre G, Bailey J, Haviv I, et al. is-rSNP: a novel technique for in silico regulatory SNP detection. Bioinformatics 2010;26:i524-30.
179. Thomas-Chollier M, Hufton A, Heinig M, et al. Transcription factor binding predictions using TRAP for the analysis of ChIP-seq data and regulatory SNPs. Nat Protoc 2011;6:1860-9.
180. Barenboim M, Manke T. ChroMoS: an integrated web tool for SNP classification, prioritization and functional interpretation. Bioinformatics 2013;29:2197-8.
181. Guo L, Du Y, Chang S, et al. rSNPBase: a database for curated regulatory SNPs. Nucleic Acids Res 2014;42:D1033-9.
182. Hu H, Huff CD, Moore B, et al. VAAST 2.0: improved variant classification and disease-gene identification using a conservation-controlled amino acid substitution matrix. Gene Epidemiol 2013;37:622-34.
183. Davydov EV, Goode DL, Sirota M, et al. Identifying a high fraction of the human genome to be under selective constraint using GERP{thorn}{thorn}. PLoS Comput Biol 2010;6:e1001025.
184. Pollard KS, Hubisz MJ, Rosenbloom KR, et al. Detection of nonneutral substitution rates on mammalian phylogenies. Genome Res 2010;20:110-21.
185. Li MJ, Wang LY, Xia Z, et al. dbPSHP: a database of recent positive selection across human populations. Nucleic Acids Res 2014;42:D910-16.
186. Khurana E, Fu Y, Colonna V, et al. Integrative annotation of variants from 1092 humans: application to cancer genomics. Science 2013;342:1235587.
187. Kircher M, Witten DM, Jain P, et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 2014;46:310-15.
188. Ritchie GR, Dunham I, Zeggini E, et al. Functional annotation of noncoding sequence variants. Nat Methods 2014;11:294-6.
189. Wang J, Zhuang J, Iyer S, et al. Factorbook.org: a Wikibased database for transcription factor-binding data generated by the ENCODE consortium. NucleicAcidsRes 2013;41:D171-6.
190. Ameur A, Rada-Iglesias A, Komorowski J, et al. Identification of candidate regulatory SNPs by combination of transcription-factor-binding site prediction, SNP genotyping and haploChIP. Nucleic Acids Res 2009;37:e85.
191. Bryzgalov LO, Antontseva EV, Matveeva MY, et al. Detection of Regulatory SNPs in Human Genome Using ChIP-seq ENCODE Data. PloS One 2013;8:e78833.
192. Li MJ, Sham PC, Wang J. FastPval: a fast and memory efficient program to calculate very low P-values from empirical distribution. Bioinformatics 2010;26:2897-9.
193. Ptashne M. On the use of the word 'epigenetic'. Curr Biol 2007;17:R233-6.
194. Beisel C, Paro R. Silencing chromatin: comparing modes and mechanisms. Nat Rev Genet 2011;12:123-35.
195. Moazed D. Mechanisms for the inheritance of chromatin states. Cell 2011;146:510-18.
196. Zhou VW, Goren A, Bernstein BE. Charting histone modifications and the functional organization of mammalian genomes. Nat RevGenet 2011;12:7-18.
197. de Wit E, de Laat W. A decade of 3C technologies: insights into nuclear organization. Genes Dev 2012;26:11-24.
198. Huang L, Yu D, Wu C, et al. Copy number variation at 6q13 functions as a long-range regulator and is associated with pancreatic cancer risk. Carcinogenesis 2012;33:94-100.
199. De S, Michor F. DNA replication timing and long-range DNA interactions predict mutational landscapes of cancer genomes. Nat Biotechnol 2011;29:1103-8.
200. Noordermeer D, de Wit E, Klous P, et al. Variegated gene expression caused by cell-specific long-range DNA interactions. Nat Cell Biol 2011;13:944-51.
201. Sanyal A, Lajoie BR, Jain G, et al. The long-range interaction landscape of gene promoters. Nature 2012;489:109-13.
202. Deng W, Lee J, Wang H, et al. Controlling long-range genomic interactions at a native locus by targeted tethering of a looping factor. Cell 2012;149:1233-44.
203. Jin F, Li Y, Dixon JR, et al. A high-resolution map of the three-dimensional chromatin interactome in human cells. Nature 2013;503:290-4.
204. Nagano T, Lubling Y, Stevens TJ, et al. Single-cell Hi-C reveals cell-to-cell variability in chromosome structure. Nature 2013;502:59-64.
205. Zhang Y, Wong CH, Birnbaum RY, et al. Chromatin connectivity maps reveal dynamic promoter-enhancer long-range associations. Nature 2013;504:306-10.
206. Duggal G, Wang H, Kingsford C. Higher-order chromatin domains link eQTLs with the expression of far-away genes. Nucleic Acids Res 2014;42:87-96.
207. Pomerantz MM, Ahmadiyeh N, Jia L, et al. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat Genet 2009;41:882-4.
208. Smemo S, Tena JJ, Kim KH, et al. Obesity-associated variants within FTO form long-range functional connections with IRX3. Nature 2014;507:371-5.
209. Kheradpour P, Kellis M. Systematic discovery and characterization of regulatory motifs in ENCODE TF binding experiments. Nucleic Acids Res 2013. doi:10.1093/nar/gkt1249 (Advance online publication 13 December 2013).
210. Guan D, Shao J, Deng Y, et al. CMGRN: a web server for constructing multilevel gene regulatory networks using ChIP-seq and gene expression data. Bioinformatics 2014;30:1190-2.
211. Kundaje A, Kyriazopoulou-Panagiotopoulou S, Libbrecht M, et al. Ubiquitous heterogeneity and asymmetry of the chromatin environment at regulatory elements. Genome Res 2012;22:1735-47.
212. Pennacchio LA, Ahituv N, Moses AM, et al. In vivo enhancer analysis of human conserved non-coding sequences. Nature 2006;444:499-502.
213. Hardison RC. Conserved noncoding sequences are reliable guides to regulatory elements. Trends Genet 2000;16:369-72.
214. Dermitzakis ET, Reymond A, Antonarakis SE. Conserved non-genic sequences-an unexpected feature of mammalian genomes. Nat RevGenet 2005;6:151-7.
215. Emison ES, McCallion AS, Kashuk CS, et al. A common sex-dependent mutation in a RET enhancer underlies Hirschsprung disease risk. Nature 2005;434:857-63.
216. Siepel A, Bejerano G, Pedersen JS, et al. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. GenomeRes 2005;15:1034-50.
217. Miller W, Rosenbloom K, Hardison RC, et al. 28-way vertebrate alignment and conservation track in the UCSC Genome Browser. Genome Res 2007;17:1797-808.
218. Chatterjee S, Bourque G, Lufkin T. Conserved and nonconserved enhancers direct tissue specific transcription in ancient germ layer specific developmental control genes. BMCDev Biol 2011;11:63.
219. King DC, Taylor J, Zhang Y, et al. Finding cis-regulatory elements using comparative genomics: some lessons from ENCODE data. Genome Res 2007;17:775-86.
220. Schmidt D, Wilson MD, Ballester B, et al. Five-vertebrate ChIP-seq reveals the evolutionary dynamics of transcription factor binding. Science 2010;328:1036-40.
221. Torkamani A, Kannan N, Taylor SS, et al. Congenital disease SNPs target lineage specific structural elements in protein kinases. ProcNatl Acad SciUSA 2008;105:9011-16.
222. Dimas AS, Deutsch S, Stranger BE, et al. Common regulatory variation impacts gene expression in a cell type-dependent manner. Science 2009;325:1246-50.
223. Fu J, Wolfs MG, Deelen P, et al. Unraveling the regulatory mechanisms underlying tissue-dependent genetic variation of gene expression. PLoS Genet 2012;8:e1002431.
224. Vernes SC, Spiteri E, Nicod J, et al. High-throughput analysis of promoter occupancy reveals direct neural targets of FOXP2, a gene mutated in speech and language disorders. AmJHum Genet 2007;81:1232-50.
225. Bhatia S, Bengani H, Fish M, et al. Disruption of autoregulatory feedback by a mutation in a remote, ultraconserved PAX6 enhancer causes aniridia. Am J Hum Genet 2013;93:1126-34.
226. Urnov FD, Rebar EJ, Holmes MC, et al. Genome editing with engineered zinc finger nucleases. NatRev Genet 2010;11:636-46.
227. Miller JC, Tan S, Qiao G, et al. A TALE nuclease architecture for efficient genome editing. NatBiotechnol 2011;29:143-8.
228. Cong L, Ran FA, Cox D, et al. Multiplex genome engineering using CRISPR/Cas systems. Science 2013;339:819-23.